Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.

International angiology : a journal of the International Union of Angiology - 1 Mar 2003

Hatzaki A, Anagnostopoulou E, Metaxa-Mariatou V, Melissinos C, Philalithis P, Iliadis K, Kontaxis A, Liberatos K, Pangratis N, Nasioulas G

Abstract excerpt

AIM: There is growing evidence that a number of genetic risk factors predispose independently to venous thrombosis and the coexistence of defective genes is involved in the manifestation and recurrence of thrombotic events. The goal of this study was to examine the efficiency of the selection criteria for performing a genetic test for the factor V G1691A (Leiden) and factor II G20210A mutations. METHODS: Blood...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Greece

Share to Heterozygote

Share to Point Mutation

Share to Prothrombin

Share to Thrombophilia

Share to Thrombosis

Source

Identifiers

PMID: 12771861

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.PMID 12771861Read ↗

Investigating the Matrix of Factor V Leiden (G1691A), Factor II Prothrombin (G2021A), MTHFR C677T and A1298G Polymorphisms in Greek Population: A Preliminary Study.Semantic proximity Read ↗

Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors.Semantic proximity Read ↗

Clinical and Molecular Study of Common Thrombophilia Mutation Prothrombin G20210A.Semantic proximity Read ↗

The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.Semantic proximity Read ↗

[Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].Semantic proximity Read ↗

Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population.Semantic proximity Read ↗

Potential prevention of thromboembolism by genetic counseling and testing for two common thrombophilia mutations.Semantic proximity Read ↗

Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the Procare Study.Semantic proximity Read ↗

Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.Semantic proximity Read ↗

Prevalence of the G20210A prothrombin gene mutation in Northwestern Greece and association with venous thromboembolism.Semantic proximity Read ↗

Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.Semantic proximity Read ↗

Prevalence of prothrombotic polymorphisms in Greece.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.